MedPath

Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Control Lens (stenfilcon A)
Device: Test Lens (senofilcon A)
Registration Number
NCT05805150
Lead Sponsor
Coopervision, Inc.
Brief Summary

The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.

Detailed Description

This study is prospective, bilateral eye, double masked, randomized, 1 week cross-over, daily wear design involving in two different daily disposable lens types. Each lens type will be worn for approximately one week.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • Is between 18 and 35 years of age (inclusively) and has full legal capacity to volunteer;

  • Has read and signed an information consent letter;

  • Self-reports having a full eye examination in the previous two years;

  • Self-reports spending on most days at least 6 hours cumulative (not necessarily in one single stretch) using digital devices such as a computer, laptop, tablet, e-reader, smartphone;

  • Anticipates being able to wear the study lenses for at least 8 hours a day, 7 days a week;

  • Is willing and able to follow instructions and maintain the appointment schedule;

  • Habitually wears soft contact lenses, for the past 3 months minimum;

    1. No more than 1/3 of participants should be habitual wearer of MyDay or MyDay Energys
    2. No more than 1/3 of participants should be habitual wearer of ACUVUE® OASYS MAX 1-Day or ACUVUE® OASYS 1-Day.
  • Has refractive astigmatism no higher than -0.75DC in each eye;

  • Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available lens parameters are sphere -1.00 to -6.00D, 0.25D steps).

Exclusion Criteria
  • Is participating in any concurrent clinical or research study;
  • Has any known active ocular disease and/or infection that contraindicates contact lens wear;
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  • Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
  • Has known sensitivity to the diagnostic sodium fluorescein used in the study;
  • Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
  • Has undergone refractive error surgery or intraocular surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Control Lens, Then Test LensTest Lens (senofilcon A)Participants will wear control lenses for one week and then crossover to test lenses for one week.
Control Lens, Then Test LensControl Lens (stenfilcon A)Participants will wear control lenses for one week and then crossover to test lenses for one week.
Test Lens, Then Control LensControl Lens (stenfilcon A)Participants will wear test lenses for one week and then crossover to control lenses for one week.
Test Lens, Then Control LensTest Lens (senofilcon A)Participants will wear test lenses for one week and then crossover to control lenses for one week.
Primary Outcome Measures
NameTimeMethod
Lens Handling on RemovalCollected once on day 6 at the end of wear

Ease of lens removal on a 0-100 scale (0= very difficult, 100= very easy)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Complete Eye Care of Medina

🇺🇸

Medina, Minnesota, United States

Kannarr Eye Care

🇺🇸

Pittsburg, Kansas, United States

Nittany Eye Associates

🇺🇸

State College, Pennsylvania, United States

West Bay Eye Associates

🇺🇸

Warwick, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath